Michael Riedel - Concepedia

Author

Michael Riedel

Also Known As

M J Riedel, M Riedel, M. J. Riedel, M. RIEDEL, M. Riedel, MICHAEL RIEDEL, Michael J Riedel, Michael J. Riedel, Michael Riedel, S. Riedel, M. Kraft, T. Kucharzik, H.

333

Publications

13.4K

Citations

H-Index

186

Concepts

All Affiliations

Ludwig-Maximilians-Universität München Heinrich Heine University Düsseldorf Charité - Universitätsmedizin Berlin University of Bonn University of Cologne

About

Michael Riedel is an author at Ludwig-Maximilians-Universität München specializing in medicine, psychiatry, and psychopathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	49	107	7.3K
2	Natural Sciences	6	6	302
3	Health Sciences	5	5	249
4	Engineering	4	4	106
5	Nursing	1	1	10

Michael Riedel

179

Publications

11.1K

Citations

H-Index

Page 1

	Year	Citations
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine Norbert Müller, Markus Schwarz, Sandra Dehning, Molecular Psychiatry PsychiatryAdd-on Pilot StudyPsychotropic MedicationSubcortical Ischemic DepressionPharmacology	2006	789
Maturation of Human Embryonic Stem Cell–Derived Pancreatic Progenitors Into Functional Islets Capable of Treating Pre-existing Diabetes in Mice Alireza Rezania, Jennifer E. Bruin, Michael Riedel, Diabetes Adult Stem CellStem Cell BiologyInsulin SignalingRegenerative MedicineStem Cells	2012	590
Beneficial Antipsychotic Effects of Celecoxib Add-On Therapy Compared to Risperidone Alone in Schizophrenia Norbert Müller, Michael Riedel, Constanze Scheppach, American Journal of Psychiatry	2002	388
Response and remission criteria in major depression – A validation of current practice Michael Riedel, Hans‐Jürgen Möller, Michael Obermeier, Journal of Psychiatric Research PsychopathologyPsychiatryDepression TreatmentMedicineMood Symptom	2010	279
Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment Norbert Müller, Daniela Krause, Sandra Dehning, Schizophrenia Research Celecoxib TreatmentPsychiatryPsychotic DisorderCelecoxib AugmentationPharmacology	2010	254
Production of Functional Glucagon-Secreting α-Cells From Human Embryonic Stem Cells Alireza Rezania, Michael Riedel, Rhonda D. Wideman, Diabetes	2010	227
Evidence for an association between a G-protein β3-gene variant with depression and response to antidepressant treatment Peter Zill, Thomas C. Baghai, Peter Zwanzger, Neuroreport	2000	196
Glucagon-Like Peptide-1 Inhibits Pancreatic ATP-Sensitive Potassium Channels via a Protein Kinase A- and ADP-Dependent Mechanism Peter E. Light, Jocelyn E. Manning Fox, Michael Riedel, Molecular Endocrinology Cellular PhysiologyInsulin SignalingGastrointestinal Peptide HormoneProtein Kinase AHyperpolarization (Biology)	2002	181
Immunohistochemical characterisation of cells co-producing insulin and glucagon in the developing human pancreas Michael Riedel, Ali Asadi, R. Wang, Diabetologia Immunohistochemical CharacterisationHuman PancreasDevelopmental BiologyPhysiologyDiabetes	2011	167
Does early improvement triggered by antidepressants predict response/remission? — Analysis of data from a naturalistic study on a large sample of inpatients with major depression Verena Henkel, Florian Seemüller, Michael Obermeier, Journal of Affective Disorders PsychopathologyPsychiatryMood SymptomAntidepressants Predict Response/remissionPsychotropic Medication	2008	165

Page 1